Company / Cash per Share
Vivos Therapeutics, Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.34
FY2025
5-year range
$0.15 / $3.82
FY2021-FY2025
Trend
-89.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.82 to $0.34 over the past 2 years.
Based on SEC 10-K filings.
0.34 in FY2025 with a 5-year CAGR of -25.1%.
Declined from $3.82 to $0.34 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +31.1%
- 5-Year CAGR
- -25.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 89.9% year-over-year.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | -89.9% |
| FY2024 | $3.41 | -10.7% |
| FY2023 | $3.82 | +2399.7% |
| FY2022 | $0.15 | -88.4% |
| FY2021 | $1.32 | -9.8% |
| FY2020 | $1.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026